Media

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

The Predictive Safety Testing Consortium enables companies to share and validate safety biomarkers.

To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administratio

Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Fo

Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-Path&#82

President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd

A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and develo

The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Con

The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of wh

The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent year

The Critical Path Institute (C-Path), today announced the appointment of Jeffrey Cossman, M.D., an internationally recognized expe

The Food and Drug Administration (FDA) and The Critical Path Institute (C-Path) today announced the formation of the Predictive Sa